» Articles » PMID: 10702287

Hepatitis C Virus NS5A Protein Modulates Transcription Through a Novel Cellular Transcription Factor SRCAP

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Mar 4
PMID 10702287
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus NS5A protein transcriptionally modulates cellular genes and promotes cell growth. NS5A is likely to exert its activity in concert with cellular factor(s). Using a yeast two-hybrid screen, we have demonstrated that NS5A interacts with the C-terminal end of a newly identified cellular transcription factor, SRCAP. The authenticity of this interaction was verified by a mammalian two-hybrid assay, in vitro pull-down experiment, and an in vivo coimmunoprecipitation assay in human hepatoma (HepG2) cells. An in vitro transient transfection assay demonstrated that SRCAP can efficiently activate transcription when recruited by the Gal4 DNA-binding domain to the promoter. However, down-regulation of p21 promoter activity by NS5A was enhanced following ectopic expression of SRCAP. Together these results suggest that the interaction of NS5A and SRCAP may be one of the mechanisms by which NS5A exerts its effect on cell growth regulation contributing to hepatitis C virus-mediated pathogenesis.

Citing Articles

SRCAP is involved in porcine reproductive and respiratory syndrome virus activated Notch signaling pathway.

Ding G, Li Y, Li D, Dou M, Fu C, Chen T J Virol. 2024; 98(12):e0121624.

PMID: 39530666 PMC: 11650989. DOI: 10.1128/jvi.01216-24.


Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling.

Wei X, Fan S, Wang Y, Li S, Long S, Gan C iScience. 2022; 25(6):104416.

PMID: 35663023 PMC: 9156947. DOI: 10.1016/j.isci.2022.104416.


LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).

Cao W, Liu X, Su W, Liang H, Tang H, Zhang W Bioengineered. 2022; 13(2):4573-4586.

PMID: 35152838 PMC: 8974044. DOI: 10.1080/21655979.2022.2031402.


Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055.

Eguchi K, Fujitani N, Nakagawa H, Miyazaki T Sci Rep. 2019; 9(1):4812.

PMID: 30886158 PMC: 6423325. DOI: 10.1038/s41598-019-39602-7.


A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.

Wijetunga N, Pascual M, Tozour J, Delahaye F, Alani M, Adeyeye M Oncogene. 2016; 36(14):2030-2044.

PMID: 27721404 PMC: 5383522. DOI: 10.1038/onc.2016.340.